pJAK2(1001âEUR"1013)

Description: pJAK2(1001â?"1013) acts as a SOCS1/3 antagonist, enhancing the JAK/STAT signaling pathway by inhibiting the negative regulatory effects of SOCS proteins, thereby playing a crucial role in antiviral immune responses. Target: JAK. Smiles: C([C@H](CC(C)C)N)(=O)N1[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@@H](CC2=CC=C(OP(=O)(O)O)C=C2)C(N[C@@H](CC3=CC=C(O)C=C3)C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(=O)N4[C@H](C(O)=O)CCC4)CCC(O)=O)=O)CCCCN)=O)C(C)C)=O)CCCCN)=O)=O)=O)CCC(O)=O)=O)CCCCN)=O)CC(O)=O)=O)CCC(N)=O)=O)CCC1